XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 2,565,244 $ 3,220,319
General and administrative 3,140,712 3,145,265
Total operating expenses 5,705,956 6,365,584
Loss from operations (5,705,956) (6,365,584)
Other income (expense):    
Interest expense (5,062) (5,063)
Interest income 85,269 53,623
Total other income, net 80,207 48,560
Net loss $ (5,625,749) $ (6,317,024)
Weighted-average shares of common stock outstanding, basic 23,537,134 19,497,731
Weighted-average shares of common stock outstanding, diluted 23,537,134 19,497,731
Net loss per share attributable to common stockholders, basic $ (0.24) $ (0.32)
Net loss per share attributable to common stockholders, diluted $ (0.24) $ (0.32)